Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction ...
Investing.com Australia5d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Bausch + Lomb announced a recall of its enVista IOLs, including Aspire, Envy, and certain lots of monofocal lenses, due to ...
Bausch + Lomb downgraded to Equal Weight from Overweight at Wells Fargo
Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24.Light Up your Portfolio ...
Bausch + Lomb cut to Equal Weight at Wells Fargo following enVista recall
Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24. The company’s announced ...
Yahoo Finance6d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Bausch + Lomb announced a recall of its enVista IOLs, including Aspire, Envy, and certain lots of monofocal lenses, due to reports of toxic anterior segment syndrome. Wells Fargo highlighted that ...
Seeking Alpha5d
Bausch + Lomb extends drop as Wells Fargo downgrades on enVista recall
Bausch + Lomb (NYSE:BLCO) continued to trade lower on Friday as Wells Fargo downgraded the Canadian eyecare firm in reaction to a voluntary recall of several brands of its enVista line of ...
Investing6d
WF downgrades Bausch + Lomb on enVista recall giving a near-term uncertainty
Investing.com -- Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to ...